14-44504955-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_032135.4(FSCB):c.2033C>A(p.Ala678Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000499 in 1,604,576 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_032135.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FSCB | NM_032135.4 | c.2033C>A | p.Ala678Asp | missense_variant | 1/1 | ENST00000340446.5 | NP_115511.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FSCB | ENST00000340446.5 | c.2033C>A | p.Ala678Asp | missense_variant | 1/1 | 6 | NM_032135.4 | ENSP00000344579.4 |
Frequencies
GnomAD3 genomes AF: 0.00000670 AC: 1AN: 149308Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000412 AC: 6AN: 1455160Hom.: 0 Cov.: 32 AF XY: 0.00000829 AC XY: 6AN XY: 723868
GnomAD4 genome AF: 0.0000134 AC: 2AN: 149416Hom.: 0 Cov.: 32 AF XY: 0.0000137 AC XY: 1AN XY: 73142
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 29, 2024 | The c.2033C>A (p.A678D) alteration is located in exon 1 (coding exon 1) of the FSCB gene. This alteration results from a C to A substitution at nucleotide position 2033, causing the alanine (A) at amino acid position 678 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at